IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro.
about
Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationshipMolecular Mechanisms of Obesity-Induced Osteoporosis and Muscle AtrophySystemic IL-6 Effector Response in Mediating Systemic Bone Loss Following Inhalation of Organic DustThe PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?MicroRNA-103a-3p controls proliferation and osteogenic differentiation of human adipose tissue-derived stromal cells.IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse.Long-Term Administration of High-Fat Diet Corrects Abnormal Bone Remodeling in the Tibiae of Interleukin-6-Deficient Mice.Bioinformatics and Microarray Analysis of miRNAs in Aged Female Mice Model Implied New Molecular Mechanisms for Impaired Fracture Healing.Regulation of Stem Cell Properties of Müller Glia by JAK/STAT and MAPK Signaling in the Mammalian Retina.Effects of strength training on osteogenic differentiation and bone strength in aging female Wistar rats.Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells.Serum of patients with active rheumatoid arthritis inhibits differentiation of osteochondrogenic precursor cells.Soluble Inflammatory Markers and Risk of Incident Fractures in Older Adults: The Cardiovascular Health Study.The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab.Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis.Maternal obesity increases insulin resistance, low-grade inflammation and osteochondrosis lesions in foals and yearlings until 18 months of age.Interferon β protects against avascular osteonecrosis through interleukin 6 inhibition and silent information regulator transcript-1 upregulation.IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways.Histological Evidence of Increased Osteoclast Cell Number and Asymmetric Bone Resorption Activity in the Tibiae of Interleukin-6-Deficient Mice.Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity on multiple myeloma bone disease.
P2860
Q28066958-BC93266E-241B-4836-9CB7-43F3358CFFBAQ28072006-4311E4AB-DE1B-4E6E-BC57-C2766103EBA6Q29048648-2B925106-0BDB-4367-84D7-C3D3940082A5Q35680138-35E71F56-72D5-4B58-AAFA-49314FE06D32Q35917405-B2AA9B92-C698-4C02-B0EE-4B59AD100DAEQ36003384-AB102EDE-33CB-4F77-934F-654DC1C12ED2Q36737095-7D031C1B-F981-4FE6-9507-B30C440C5672Q37209989-1428426C-AE73-4E61-8C8C-0EB850CB38C1Q37615060-721BAAC2-A9E5-4DDB-871A-0059C37585B2Q37648796-364211ED-C551-49FF-85FB-53C6F03BB98DQ37690945-3884DED5-E49A-40A2-A049-CCDF7EDC4239Q38780341-C3B3124B-499D-4153-B684-E5B5C22F641EQ46056287-D4A86C66-0706-43BD-9EC1-ADFD0DAFB796Q47620622-68FC2B93-A74D-4108-B85F-EAD241BD4AF8Q47679545-3F8FA55A-0885-45AD-B09D-EAE5E4F278C6Q48159131-5B0472F5-196B-4FC5-9C6F-04C807DDE462Q49225614-96BEC16C-064F-4AFF-8013-CBB7117D8146Q49357657-80B8B8D0-8F64-44D0-A8A4-C221652EE760Q50662652-A49FC8B7-C4D6-41B1-9524-4D965D6A1A58Q53141245-66B757EA-8597-405E-BA56-11CC107625F5Q54110801-6C398D8E-AD8D-4F80-B598-11503C772BF8
P2860
IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
IL-6 negatively regulates oste ...... d SHP2/Akt2 pathways in vitro.
@en
IL-6 negatively regulates oste ...... d SHP2/Akt2 pathways in vitro.
@nl
type
label
IL-6 negatively regulates oste ...... d SHP2/Akt2 pathways in vitro.
@en
IL-6 negatively regulates oste ...... d SHP2/Akt2 pathways in vitro.
@nl
prefLabel
IL-6 negatively regulates oste ...... d SHP2/Akt2 pathways in vitro.
@en
IL-6 negatively regulates oste ...... d SHP2/Akt2 pathways in vitro.
@nl
P2093
P2860
P1476
IL-6 negatively regulates oste ...... d SHP2/Akt2 pathways in vitro.
@en
P2093
Chikahisa Higuchi
Hideki Yoshikawa
Jun Hashimoto
Kenrin Shi
Kosuke Ebina
Kota Koizumi
Makoto Hirao
Michio Okamoto
Shoichi Kaneshiro
Tokimitsu Morimoto
P2860
P2888
P304
P356
10.1007/S00774-013-0514-1
P577
2014-07-01T00:00:00Z